Eyeworld Supplements

ASCRS Clinical Survey 2014

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/407716

Contents of this Issue

Navigation

Page 6 of 7

7 Post-Cataract Surgery Inflammation Inflammation plays an integral role in patient satisfaction, outcomes, and overall surgical success. Modern therapies and patient expectations help doctors progress toward the minimization, and eventual elimination, of post-cataract surgery inflammation. More than 1/3 of ASCRS members expect 1+ cell/flare as a normal level of inflammation 3–7 days after cataract surgery. Additionally, 40.2% are using BOTH NSAIDs and steroids at 1 day postop. Laser Vision Correction Advanced diagnostics and newer ablation profiles have routinely driven outcomes to exceed 20/20 UCVA once used as a successful measurement. New data has also demonstrated there may be a gap in the perceived and true incidence of dry eye and ectasia rates with LASIK. The large majority of respondents use 20/20 UCVA or have no standardized way of assessing a successful laser vision correction procedure. Additionally, respondents believe that LASIK has increased dry eye in 32% of patients, and 1/3 routinely use the Randleman criteria to determine LASIK vs. PRK candidacy.

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - ASCRS Clinical Survey 2014